Sebi bars Nirman Agri Genetics and promoter from markets after finding IPO funds diverted – News Air Insight

Spread the love


Capital markets regulator Sebi has passed an interim order against Nirman Agri Genetics (NAGL) and its promoter Pranav Kailas Bagal, restraining them from accessing the securities market. Sebi found that nearly the entire IPO proceeds were allegedly diverted to bogus entities and promoter-linked firms.

The Nashik-based company, which raised Rs 20.3 crore through its SME IPO in March 2023, was found to have misused around Rs 18.89 crore (93% of the issue amount), according to Sebi’s 19-page order signed by Whole-Time Member Kamlesh Chandra Varshney.

The investigation began after similarities were found between NAGL’s fund movements and those in the Synoptics Technologies case, both handled by merchant banker First Overseas Capital. The probe revealed that NAGL had provided conflicting information about its IPO fund utilisation and failed to produce any valid agreements or invoices for payments made to several vendors.

Bogus transactions and forged licenses

The regulator found that large portions of the IPO money were sent to four entities — Janvi Traders, Lalit Traders, Somnath Agriculture Trading Co, and VN Enterprise — which were either non-existent or linked to unrelated individuals.

In one instance, Sebi found that Janvi Traders used a forged APMC license and withdrew Rs 5 crore in cash on the same day it received Rs 2.5 crore from NAGL. Site visits by NSE officials confirmed that none of these entities operated at their registered addresses.


Further scrutiny of bank statements showed that NAGL routed another Rs 6.75 crore through shell firms, ultimately landing in the personal or family accounts of the company’s promoter. Funds were traced to entities owned by Pranav Bagal’s father, mother, uncle, cousin, and even an independent director, suggesting a complex web of insider transactions.

Promoter share sales raise alarm

Sebi observed that promoter Pranav Bagal sold about 8.6 lakh shares, or 10.7% of NAGL’s equity, in September 2025, netting Rs 16.08 crore. The regulator said these sales were executed “at prices based on misstated financials,” posing a risk of further offloading and potential harm to retail investors.NAGL’s promoter holding fell from 65.6% at listing to 44.3% by September 2025, even as the number of public shareholders rose nearly fourfold in two years.

Adding to investor concerns, Sebi noted that the company recently proposed a stock split, bonus issue, and a name change to Agriicare Life Crop, which the regulator described as part of “a larger scheme to deceive investors.”

Add ET Logo as a Reliable and Trusted News Source

Pending further investigation, Sebi has restrained the company and its promoter from accessing or dealing in the securities market and barred NAGL from proceeding with the proposed bonus and stock split.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *